• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

常见非整倍体筛查中无创产前检测方法准确性差异的系统评价

Systematic Review of Accuracy Differences in NIPT Methods for Common Aneuploidy Screening.

作者信息

Marton Tamas, Erdélyi Zsófia R, Takai Minori, Mészáros Balázs, Supák Dorina, Ács Nándor, Kukor Zoltán, Herold Zoltan, Hargitai Beata, Valent Sándor

机构信息

Department of Obstetrics and Gynecology, Semmelweis University, 1082 Budapest, Hungary.

Institute of Biochemistry and Molecular Biology, Department of Molecular Biology, Semmelweis University, 1094 Budapest, Hungary.

出版信息

J Clin Med. 2025 Apr 18;14(8):2813. doi: 10.3390/jcm14082813.

DOI:10.3390/jcm14082813
PMID:40283645
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12028023/
Abstract

Non-invasive prenatal testing (NIPT) has become a widely used method for screening common fetal aneuploidies due to its high sensitivity and specificity compared to traditional screening methods. With various NIPT technologies available, such as whole-genome sequencing (WGS), single nucleotide polymorphisms (SNPs), microarray, and rolling circle amplification (RCA), understanding the accuracy and reliability of each method is critical for clinical decision-making. However, comprehensive evaluations comparing the performance of these NIPT methods, especially in terms of predictive values for trisomy detection, remain limited. A systematic review of the difference in accuracy of the different NIPT methods used for common aneuploidy screening. A systematic review of former clinical studies using different NIPT methods, such as whole-genome sequencing (WGS), a targeted method of single nucleotide polymorphisms (SNPs), microarray and rolling circle amplification (RCA). We collected data from the PubMed, Embase, Web of Science, Scopus, clinicaltrials.gov, and Cochrane library from the last 20 years, between 2003 January and 2023 October, without any language, search filter or publication type restrictions. Two authors selected twenty articles including twenty-one studies to perform the systematic review. In these studies, altogether 92,164 pregnant women were tested by genomics-based non-invasive prenatal testing (NIPT). We extracted data on true positive, false positive, false negative, and true negative values from each study, and calculated sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) from them. We collected data regarding trisomy 21 (T21), trisomy 18 (T18) and trisomy 13 (T13) detection from all studies. As a conclusion, for the detection of common fetal trisomies, different methods of NIPT perform similarly in terms of clinical sensitivity, specificity and NPV. However, the tests utilizing SNP and RCA had lower PPV values than other NIPT methods. Our research indicates all NIPT methods showed greater sensitivity for the detection of T21, above 97%, than traditional screening tests. For T18 detection, the targeted method with the microarray had a lower sensitivity compared to other tests. The SNP and the microarray-based test had high PPV, whilst the other tests, utilizing WGS, and the test with RCA had quite low PPV. Regarding T13 detection, all of the tests performed similarly in terms of clinical sensitivity, specificity, PPV, and NPV (with one exception-one of the tests using WGS had lower PPV). According to these results, there was no significant difference between the methods of NIPT, such as WGS, SNPs, microarray, and RCA, used to detect common trisomies, but the variation in PPV underlines the importance of invasive tests to derive positive NIPT results. We suggest that NIPT combined with US screening for structural abnormalities could further improve the utility of the non-invasive tests in pregnancy. This is the first independent systematic review into the efficacy of the different NIPT methods.

摘要

与传统筛查方法相比,无创产前检测(NIPT)因其高灵敏度和特异性,已成为广泛应用于常见胎儿非整倍体筛查的方法。随着各种NIPT技术的出现,如全基因组测序(WGS)、单核苷酸多态性(SNP)、微阵列和滚环扩增(RCA),了解每种方法的准确性和可靠性对于临床决策至关重要。然而,比较这些NIPT方法性能的综合评估仍然有限,尤其是在三体检测的预测值方面。对用于常见非整倍体筛查的不同NIPT方法准确性差异的系统评价。对以前使用不同NIPT方法的临床研究进行系统评价,如全基因组测序(WGS)、单核苷酸多态性(SNP)的靶向方法、微阵列和滚环扩增(RCA)。我们从2003年1月至2023年10月的过去20年中,从PubMed、Embase、科学网、Scopus、clinicaltrials.gov和Cochrane图书馆收集数据,没有任何语言、搜索过滤器或出版物类型限制。两位作者选择了20篇文章,包括21项研究进行系统评价。在这些研究中,共有92164名孕妇接受了基于基因组学的无创产前检测(NIPT)。我们从每项研究中提取真阳性、假阳性、假阴性和真阴性值的数据,并据此计算灵敏度、特异性、阳性预测值(PPV)和阴性预测值(NPV)。我们从所有研究中收集了关于21三体(T21)、18三体(T18)和13三体(T13)检测的数据。结论是,对于常见胎儿三体的检测,不同的NIPT方法在临床灵敏度、特异性和NPV方面表现相似。然而,利用SNP和RCA的检测方法的PPV值低于其他NIPT方法。我们的研究表明,所有NIPT方法对T21的检测灵敏度都高于97%,高于传统筛查试验。对于T18检测,微阵列靶向方法的灵敏度低于其他检测方法。基于SNP和微阵列的检测方法具有较高的PPV,而其他利用WGS的检测方法以及RCA检测方法的PPV相当低。关于T13检测,所有检测方法在临床灵敏度、特异性、PPV和NPV方面表现相似(有一个例外——使用WGS的检测方法之一的PPV较低)。根据这些结果,用于检测常见三体的NIPT方法,如WGS、SNP、微阵列和RCA之间没有显著差异,但PPV的差异突出了侵入性检测对获得阳性NIPT结果的重要性。我们建议NIPT与超声筛查结构异常相结合,可以进一步提高无创检测在孕期的实用性。这是对不同NIPT方法疗效的首次独立系统评价。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5f4/12028023/8f446be61754/jcm-14-02813-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5f4/12028023/8f446be61754/jcm-14-02813-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5f4/12028023/8f446be61754/jcm-14-02813-g001.jpg

相似文献

1
Systematic Review of Accuracy Differences in NIPT Methods for Common Aneuploidy Screening.常见非整倍体筛查中无创产前检测方法准确性差异的系统评价
J Clin Med. 2025 Apr 18;14(8):2813. doi: 10.3390/jcm14082813.
2
Genomics-based non-invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women.基于基因组学的非侵入性产前检测用于检测孕妇胎儿染色体非整倍体。
Cochrane Database Syst Rev. 2017 Nov 10;11(11):CD011767. doi: 10.1002/14651858.CD011767.pub2.
3
Non-invasive prenatal test findings in 41,819 pregnant women: results from a clinical laboratory in southern China.在中国南方的一家临床实验室中,对 41819 名孕妇进行了无创性产前检测结果分析。
Arch Gynecol Obstet. 2023 Sep;308(3):787-795. doi: 10.1007/s00404-022-06908-3. Epub 2023 Jan 5.
4
Late first-trimester ultrasound findings can alter management after high-risk NIPT result.早孕期超声检查结果可改变高危 NIPT 结果后的处理方式。
Ultrasound Obstet Gynecol. 2023 Oct;62(4):497-503. doi: 10.1002/uog.26272.
5
Evaluation of the Z-score accuracy of noninvasive prenatal testing for fetal trisomies 13, 18 and 21 at a single center.单中心无创性产前检测胎儿 13、18 和 21 三体的 Z 评分准确性评估。
Prenat Diagn. 2021 May;41(6):690-696. doi: 10.1002/pd.5908. Epub 2021 Feb 11.
6
Clinical performance of non-invasive prenatal served as a first-tier screening test for trisomy 21, 18, 13 and sex chromosome aneuploidy in a pilot city in China.在中国一个试点城市,非侵入性产前检测在 21 三体、18 三体、13 三体和性染色体非整倍体的一线筛查中表现出良好的临床性能。
Hum Genomics. 2020 Jun 5;14(1):21. doi: 10.1186/s40246-020-00268-2.
7
Non-invasive prenatal testing for the detection of trisomies 21, 18, and 13 in pregnant women with various clinical indications: A multicenter observational study of 1,854,148 women in China.中国多中心研究:1854148 例具有不同临床指征孕妇的非侵入性产前检测在检测 21、18、13 三体中的应用。
Prenat Diagn. 2023 Jul;43(8):1036-1043. doi: 10.1002/pd.6312. Epub 2023 Jan 27.
8
Non-invasive prenatal testing for the detection of trisomy 13, 18, and 21 and sex chromosome aneuploidies in 68,763 cases.对68763例病例进行无创产前检测以检测13、18和21三体以及性染色体非整倍体。
Front Genet. 2022 Sep 15;13:864076. doi: 10.3389/fgene.2022.864076. eCollection 2022.
9
Performance of cell-free DNA sequencing-based non-invasive prenatal testing: experience on 36,456 singleton and multiple pregnancies.基于游离细胞 DNA 测序的无创性产前检测的性能:36456 例单胎和多胎妊娠的经验。
BMC Med Genomics. 2021 Mar 30;14(1):93. doi: 10.1186/s12920-021-00941-y.
10
A dPCR-NIPT assay for detections of trisomies 21, 18 and 13 in a single-tube reaction-could it replace serum biochemical tests as a primary maternal plasma screening tool?一种用于在单个反应管中检测 21、18 和 13 三体的 dPCR-NIPT 检测方法——它能否取代血清生化检测作为主要的母体血浆筛查工具?
J Transl Med. 2022 Jun 15;20(1):269. doi: 10.1186/s12967-022-03455-y.

本文引用的文献

1
Non-Invasive Prenatal Testing (NIPT): Reliability, Challenges, and Future Directions.无创产前检测(NIPT):可靠性、挑战与未来方向。
Diagnostics (Basel). 2023 Aug 2;13(15):2570. doi: 10.3390/diagnostics13152570.
2
Position statement from the International Society for Prenatal Diagnosis on the use of non-invasive prenatal testing for the detection of fetal chromosomal conditions in singleton pregnancies.国际产前诊断学会关于在单胎妊娠中使用无创产前检测来检测胎儿染色体疾病的立场声明。
Prenat Diagn. 2023 Jun;43(7):814-828. doi: 10.1002/pd.6357. Epub 2023 May 16.
3
Non-Invasive prenatal testing with rolling circle amplification: Real-world clinical experience in a non-molecular laboratory.
滚环扩增的无创性产前检测:非分子实验室的真实临床经验。
J Clin Lab Anal. 2023 Mar;37(6):e24870. doi: 10.1002/jcla.24870. Epub 2023 Mar 27.
4
Tutorial: statistical methods for the meta-analysis of diagnostic test accuracy studies.教程:诊断测试准确性研究的荟萃分析统计方法。
Clin Chem Lab Med. 2023 Jan 19;61(5):777-794. doi: 10.1515/cclm-2022-1256. Print 2023 Apr 25.
5
Assessment of a Simplified Cell-Free DNA Method for Prenatal Down Syndrome Screening.简化的游离胎儿 DNA 方法用于产前唐氏综合征筛查的评估。
Clin Chem. 2022 Nov 3;68(11):1449-1458. doi: 10.1093/clinchem/hvac131.
6
Cell-free DNA analysis for noninvasive examination of trisomy: comparing 2 targeted methods.用于三体性无创检测的游离DNA分析:比较两种靶向方法。
Am J Obstet Gynecol. 2022 Sep;227(3):539-541. doi: 10.1016/j.ajog.2022.05.024. Epub 2022 May 14.
7
Non-invasive prenatal screening for fetal triploidy using single nucleotide polymorphism-based testing: Differential diagnosis and clinical management in cases showing an extra haplotype.使用基于单核苷酸多态性检测的无创性产前筛查胎儿三倍体:显示额外单倍型病例的鉴别诊断和临床管理。
Prenat Diagn. 2022 Jul;42(8):994-999. doi: 10.1002/pd.6169. Epub 2022 May 21.
8
Health economic evaluation of noninvasive prenatal testing and serum screening for down syndrome.非侵入性产前检测和唐氏综合征血清筛查的健康经济评估。
PLoS One. 2022 Apr 14;17(4):e0266718. doi: 10.1371/journal.pone.0266718. eCollection 2022.
9
Application of ultrasound combined with noninvasive prenatal testing in prenatal testing.超声联合无创产前检测在产前检测中的应用
Transl Pediatr. 2022 Jan;11(1):85-98. doi: 10.21037/tp-21-617.
10
Clinical Validation of Fetal cfDNA Analysis Using Rolling-Circle-Replication and Imaging Technology in Osaka (CRITO Study).大阪胎儿游离DNA分析的滚环复制及成像技术临床验证(CRITO研究)
Diagnostics (Basel). 2021 Oct 4;11(10):1837. doi: 10.3390/diagnostics11101837.